Accordingly, augmenting potassium efflux in tumor‐specific T cells by overexpressing the potassium channel Kv1.3 lowers [K+], improves effector functions in vitro and in vivo, and enhances tumor clearance and survival in melanoma‐bearing mice [83]. The gene discussed is KCNA3; the disease is neoplasm.